These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4740778)

  • 1. Diminution of phenethylamine in the urine of Parkinson patients.
    Heller B; Fischer E
    Arzneimittelforschung; 1973 Jun; 23(6):884-6. PubMed ID: 4740778
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia and pink spot.
    Stam FC; Heslinga FJ; van Tilburg W
    Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics].
    Zimmermann K; Moschke P; Wieder KH
    Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pink spot in childhood schizophrenia.
    Widelitz MM; Feldman W
    Behav Neuropsychiatry; 1969 Apr; 1(1):29-30. PubMed ID: 5398088
    [No Abstract]   [Full Text] [Related]  

  • 5. The identity of the so-called pink spot in schizophrenia and Parkinson's disease.
    Heslinga FJ; van Tilburg W; Stam FC
    Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative gas-chromatographic determination and infrared spectrographic identification of urinary phenethylamine.
    Fischer E; Spatz H; Fernández Labriola RS; Rodriguez Casanova EM; Spatz N
    Biol Psychiatry; 1973 Oct; 7(2):161-5. PubMed ID: 4748848
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultraviolet spectrophotometric determination of 2-phenylethylamine in biological samples and its possible correlation with depression.
    Mosnaim AD; Inwang EE; Sugerman JH; DeMartini WJ; Sabelli HC
    Biol Psychiatry; 1973 Jun; 6(3):235-57. PubMed ID: 4732254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in the urine of acute schizophrenics (author's transl)].
    Braun G; Kalbhen DA; Müller J; Vahar-Matiar H
    Arch Psychiatr Nervenkr (1970); 1974 Mar; 218(3):195-210. PubMed ID: 4838948
    [No Abstract]   [Full Text] [Related]  

  • 9. The phenethylamine hypothesis of thymic homeostasis.
    Fischer E
    Biol Psychiatry; 1975 Dec; 10(6):667-73. PubMed ID: 1201323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenethylamine in normal urine: failure to verify high values.
    Schweitzer JW; Friedhoff AJ; Schwartz R
    Biol Psychiatry; 1975 Jun; 10(3):277-85. PubMed ID: 1095082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolites in Parkinson's disease.
    Kuehl FA; Vandenheuvel WJ; Ormond RE
    Nature; 1968 Jan; 217(5124):136-8. PubMed ID: 5638146
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of 3,4-dimethoxyphenylethylamine in Parkinson's disease.
    Rinne UK; Sonninen V
    Nature; 1967 Nov; 216(5114):489. PubMed ID: 6057254
    [No Abstract]   [Full Text] [Related]  

  • 14. 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia.
    Narasimhachari N
    Biol Psychiatry; 1979 Feb; 14(1):215-9. PubMed ID: 420902
    [No Abstract]   [Full Text] [Related]  

  • 15. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heboid onset of the progressive forms of juvenile schizophrenia (clinical picture and prognosis based on late follow-up findings)].
    Eliava VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):107-15. PubMed ID: 7180295
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychomimetic compounds in the urine of schizophrenics. I. Study of catechol derivatives: so-called Pink Spot and 3.4-dimethoxyphenylethylamine (DMPEA)].
    Willmann PK; Bidziński A; Jakimow B; Puzyński S
    Psychiatr Pol; 1977; 11(2):143-9. PubMed ID: 887672
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of schizophrenia].
    Henry J
    Soins Psychiatr; 1981 Dec; (14):7-13. PubMed ID: 6917427
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary elimination of phenethylamine.
    Fischer E; Spatz H; Saavedra JM; Reggiani H; Miró AH; Heller B
    Biol Psychiatry; 1972 Oct; 5(2):139-47. PubMed ID: 5086955
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenethylamine as a neurohumoral agent in brain.
    Fischer E; Heller B
    Behav Neuropsychiatry; 1972; 4(3-4):8-11 passim. PubMed ID: 4403640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.